TIMOLOL MALEATE solution/ drops United States - English - NLM (National Library of Medicine)

timolol maleate solution/ drops

akorn - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 5 mg in 1 ml - timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease [see warnings ]; (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure [see warnings ]; (7) cardiogenic shock; or (8) hypersensitivity to any component of this product. timolol maleate ophthalmic solution, usp 0.5% (ti-moe-lahl mal-ee-ate) read this instructions for use that comes with timolol maleate ophthalmic solution before you start using it and each time you get a refill. there may be new information. this information does not take the place of talking with your doctor about your medical condition or treatment. important information about timolol maleate ophthalmic solution: how should i use timolol maleate ophthalmic solution? step 1. wash your

TIMOLOL GFS- timolol maleate solution, gel forming / drops United States - English - NLM (National Library of Medicine)

timolol gfs- timolol maleate solution, gel forming / drops

sandoz inc - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 5 mg in 1 ml - timolol gfs 0.25% and 0.5% are indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol gfs is contraindicated in patients with: • bronchial asthma • history of bronchial asthma • severe chronic obstructive pulmonary disease • sinus bradycardia • second or third degree atrioventricular block • overt cardiac failure • cardiogenic shock • hypersensitivity to any component of this product. teratogenic effects pregnancy category c: teratogenicity studies with timolol in mice, rats, and rabbits at oral doses up to 50 mg/kg/day (7,000 times the systemic exposure following the maximum recommended human ophthalmic dose) demonstrated no evidence of fetal malformations. although delayed fetal ossification was observed at this dose in rats, there were no adverse effects on postnatal development of offspring. doses of 1,000 mg/kg/day (142,000 times the systemic exposure following the maximum recommended human ophthalmic dose) were maternotoxic in

TIMOLOL MALEATE solution/ drops United States - English - NLM (National Library of Medicine)

timolol maleate solution/ drops

pacific pharma, inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 2.5 mg in 1 ml - timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.

TIMOLOL MALEATE solution United States - English - NLM (National Library of Medicine)

timolol maleate solution

physicians total care, inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 6.8 mg in 1 ml - timolol maleate ophthalmic gel forming solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate ophthalmic gel forming solution is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.

TIMOLOL TABLET Canada - English - Health Canada

timolol tablet

aa pharma inc - timolol maleate - tablet - 5mg - timolol maleate 5mg - beta-adrenergic blocking agents

TIMOLOL TABLET Canada - English - Health Canada

timolol tablet

aa pharma inc - timolol maleate - tablet - 10mg - timolol maleate 10mg - beta-adrenergic blocking agents

TIMOLOL TABLET Canada - English - Health Canada

timolol tablet

aa pharma inc - timolol maleate - tablet - 20mg - timolol maleate 20mg - beta-adrenergic blocking agents

TIMOLOL-20 TAB 20MG TABLET Canada - English - Health Canada

timolol-20 tab 20mg tablet

pro doc limitee - timolol maleate - tablet - 20mg - timolol maleate 20mg - beta-adrenergic blocking agents

TIMOLOL-10 TAB 10MG TABLET Canada - English - Health Canada

timolol-10 tab 10mg tablet

pro doc limitee - timolol maleate - tablet - 10mg - timolol maleate 10mg - beta-adrenergic blocking agents

TIMOLOL-5 TAB 5MG TABLET Canada - English - Health Canada

timolol-5 tab 5mg tablet

pro doc limitee - timolol maleate - tablet - 5mg - timolol maleate 5mg - beta-adrenergic blocking agents